Apixaban and Cachexia - a phase IV clinical study of FDA data

Summary:

Cachexia is reported as a side effect among people who take Apixaban (apixaban), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Torsemide, and have Ascites.

The phase IV clinical study analyzes which people have Cachexia when taking Apixaban. It is created by eHealthMe based on reports of 60,044 people who have side effects when taking Apixaban from the FDA, and is updated regularly.

What is Apixaban?

Apixaban has active ingredients of apixaban. It is often used in blood clots. eHealthMe is studying from 60,342 Apixaban users. Check the latest studies of Apixaban.

What is Cachexia?

Cachexia (loss of weight) is found to be associated with 704 drugs and 1,197 conditions by eHealthMe. Check the latest studies of Cachexia.

On Nov, 20, 2025

60,044 people reported to have side effects when taking Apixaban.
Among them, 35 people (0.06%) have Cachexia.

Among these 35 people:

How long have people been on Apixaban when they have Cachexia? *

What is the gender of people who have Cachexia when taking Apixaban? *

female: 6.25 %
male: 93.75 %

What is the age of people who have Cachexia when taking Apixaban? *

What are other drugs people take besides Apixaban? *

What are other side effects people have besides Cachexia? *

General Physical Health Deterioration (weak health status): 29 people, 82.86%
Anaemia (lack of blood): 29 people, 82.86%
Arrhythmias (irregular heartbeat): 27 people, 77.14%
Depressed Level Of Consciousness: 27 people, 77.14%
Dehydration (dryness resulting from the removal of water): 25 people, 71.43%
Fatigue (feeling of tiredness): 24 people, 68.57%
Hyperglycemia (high blood sugar): 22 people, 62.86%
Tenderness (pain or discomfort when an affected area is touched): 22 people, 62.86%
Pain: 22 people, 62.86%
Nausea And Vomiting: 22 people, 62.86%

What are the existing conditions these people have? *

Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 2 people, 5.71%
Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 2 people, 5.71%
Pain: 2 people, 5.71%
Multiple Myeloma (cancer of the plasma cells): 2 people, 5.71%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 5.71%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 5.71%
Flatulence (flatus expelled through the anus): 2 people, 5.71%
Bone Loss: 2 people, 5.71%
Atrial Thrombosis (blood clot that develops in an artery): 2 people, 5.71%
Ascites (accumulation of fluid in the abdominal cavity): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Apixaban and have Cachexia?

- Check whether Cachexia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Apixaban:

Apixaban (60,342 reports)

Cachexia treatments and more:

Cachexia (7,763 reports)

Browse all side effects of Apixaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cachexia:

Cachexia (704 drugs)

Browse all the conditions that are associated with Cachexia:

Cachexia (1,197 conditions)

Drugs similar to Apixaban and Cachexia :

How the study uses the data?

The study uses data from the FDA. It is based on apixaban (the active ingredients of Apixaban) and Apixaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.